Expert Outlook: Myriad Genetics Through The Eyes Of 8 Analysts – Myriad Genetics (NASDAQ:MYGN)
Myriad Genetics: Analyst Optimism Wanes Amid Mixed Signals Over the past three months, Myriad Genetics (MYGN) has seen a shift in analyst sentiment, according to a recent evaluation by eight industry experts. While bullishness still exists, it’s tempered by a notable increase in the number of "somewhat bullish" and "indifferent" ratings, highlighting a growing sense … Read more